Recombinant hirudin for unstable angina pectoris a multicenter, randomized angiographic trial.
Times cited: 167
Thrombolysis in myocardial infarction (TIMI) trial-Phase I: Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase.
Journal of the American College of Cardiology.
Times cited: 789